Scholarlink

<p>Solid organ transplant recipients (SOTRs) develop a greater number and aggressive cutaneous squamous cell carcinomas (cSCC). Additionally, poor histological differentiation has been associated with worse clinical outcomes. Here, we examined the evolution of histological differentiation of new cSCCs post-transplant, seeking to determine whether development of poorly differentiated tumors is random or a stepwise event. We performed a retrospective cohort study at Columbia University Irving Medical Center examining 48 patients (22 SOTRs; 26 non-SOTRs) with 228 tumors (157 SOTRs; 71 non-SOTRs). On average, SOTRs developed a greater number of cSCCs compared to non-SOTRs (7.14 vs. 2.73, <i>p</i> = 0.007). There was a difference in distribution of the histologic differentiation in the final cSCC between groups with SOTRs exhibiting a higher proportion of poorly differentiated tumors (<i>p</i> = 0.009). A greater proportion of patients with sequential loss of tumor differentiation from the first tumor to last tumor was found in SOTRs versus non-SOTRs (41% vs. 4%; <i>p</i> = 0.002). In SOTRs, death was more likely related to cSCC (32% vs. 4.5%, <i>p</i> = 0.03). cSCC differentiation was associated with cSCC-related death for both SOTRs (ρ=-0.699, <i>p</i> &lt; 0.001) and non-SOTRs (ρ=-0.549, <i>p</i> = 0.008). In SOTRs, new cSCCs undergo an evolution over time, with gradual loss of histological differentiation post-transplant. In SOTRs, the change in histologic differentiation of cSCCs towards less differentiated tumors is a signal of adverse futures outcomes. This highlights the importance of considering alternative surveillance strategies, earlier introduction of changes to immunosuppression regimens, and more aggressive therapeutic options as patients begin to develop less differentiated tumors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evolution of histology of new cutaneous squamous cell carcinomas over time in solid organ transplant recipients

  • 期刊论文

  • 发表日期：

    2025年7月1日

查看全文
  • Megan H. Trager,
  • Emily R. Gordon,
  • Alyssa Breneman,
  • Tessa LeWitt,
  • Jiying Han,
  • Cheng-Shiun Leu,
  • Nisrine Kawa,
  • Sameera Husain,
  • Mariam El-Ashmawy,
  • Faramarz H. Samie

摘要

Solid organ transplant recipients (SOTRs) develop a greater number and aggressive cutaneous squamous cell carcinomas (cSCC). Additionally, poor histological differentiation has been associated with worse clinical outcomes. Here, we examined the evolution of histological differentiation of new cSCCs post-transplant, seeking to determine whether development of poorly differentiated tumors is random or a stepwise event. We performed a retrospective cohort study at Columbia University Irving Medical Center examining 48 patients (22 SOTRs; 26 non-SOTRs) with 228 tumors (157 SOTRs; 71 non-SOTRs). On average, SOTRs developed a greater number of cSCCs compared to non-SOTRs (7.14 vs. 2.73, p = 0.007). There was a difference in distribution of the histologic differentiation in the final cSCC between groups with SOTRs exhibiting a higher proportion of poorly differentiated tumors (p = 0.009). A greater proportion of patients with sequential loss of tumor differentiation from the first tumor to last tumor was found in SOTRs versus non-SOTRs (41% vs. 4%; p = 0.002). In SOTRs, death was more likely related to cSCC (32% vs. 4.5%, p = 0.03). cSCC differentiation was associated with cSCC-related death for both SOTRs (ρ=-0.699, p < 0.001) and non-SOTRs (ρ=-0.549, p = 0.008). In SOTRs, new cSCCs undergo an evolution over time, with gradual loss of histological differentiation post-transplant. In SOTRs, the change in histologic differentiation of cSCCs towards less differentiated tumors is a signal of adverse futures outcomes. This highlights the importance of considering alternative surveillance strategies, earlier introduction of changes to immunosuppression regimens, and more aggressive therapeutic options as patients begin to develop less differentiated tumors.